<DOC>
	<DOCNO>NCT01144247</DOCNO>
	<brief_summary>The purpose research study determine treat recurrent malignant glioma another person 's ( donor ) immune system cell know aCTL cell , safe . This study also try determine person receive aCTL 's less likely survive brain tumor person similar tumor past . Approximately 15 patient enrol UCLA .</brief_summary>
	<brief_title>Cellular Immunotherapy Study Brain Cancer</brief_title>
	<detailed_description />
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Astrocytoma</mesh_term>
	<mesh_term>Oligodendroglioma</mesh_term>
	<mesh_term>Meningioma</mesh_term>
	<criteria>INCLUSION CRITERIA To participate clinical trial , patient must meet following eligibility criterion : 1 . Subjects must histologically prove diagnosis malignant glioma meningioma treat prior standard radiation chemotherapy . There must evidence unequivocal progression MRI . 2 . Tumor must amenable resection , surgical resection must clinically indicate . 3 . Age least 18 year . 4 . Karnofsky performance scale score &gt; 60 . 5 . Adequate hematologic function : ) systemic white blood cell count great 2 x 103/mm3 , b ) platelet count great 100,000/mm3 , c ) hematocrit great 25 % . 6 . Adequate renal function , creatinine less two time upper limit . 7 . Adequate hepatic function , SGOT , alkaline phosphatase , total bilirubin &lt; 2x upper limit normal . 8 . Patients must expect survival least three month . 9 . Patients must history HTLV , HIV , syphilis RPR , hepatitis B C. 10 . Patients must sign informed consent . EXCLUSION CRITERIA Patients exclude trial patient : 1. multifocal tumor , bihemispheric tumor , infratentorial tumor , nonsurgically accessible tumor . 2. prior tumor resection ventricle extensively breach . 3. pregnant breastfeed woman . 4. female childbearing potential unable unwilling practice adequate birth control method . 5. contraindication brain MRI scanning ( e.g. , intraocular metal fragment , cerebral aneurysm clip , pacemaker ) . 6. concurrent malignancy , exclude curatively treat basal squamous cell carcinoma skin , carcinoma situ cervix . 7. concurrent systemic infection . 8. clinically significant , uncontrolled medical illness , determine investigator . 9. unwilling unable comply procedure require protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Recurrent Grade III Grade IV Gliomas</keyword>
	<keyword>anaplastic astrocytoma</keyword>
	<keyword>anaplastic oligodendroglioma</keyword>
	<keyword>anaplastic mixed glioma</keyword>
	<keyword>glioblastoma multiforme</keyword>
	<keyword>biotherapy</keyword>
	<keyword>malignant meningioma</keyword>
</DOC>